Moderna (MRNA) stock pushed meaningfully higher on Friday following reports that the biotech giant is leveraging its mRNA platform to develop a vaccine for hantavirus. The news, which arrived after a deadly Hantavirus outbreak on the MV Hondius cruise ship, helped MRNA break above key resistance levels coinciding with its 20-day and 50-day MA. More News from Barchart Including recent gains, Moderna stock is up nearly 80% versus the start of this year. www.barchart.com Significance of Hantavirus Outb ...